U.S. Stock News

This article examines whether Abbott Laboratories could be presenting a value opportunity after a difficult period in the market, and breaks down what the current share price might be offering. The stock last closed at US$87.01. Recent returns show a 4.2% decline over 7 days, a 14.6% decline over 30 days, and a 29.9% decline year to date, including a 33.7% decline over the past year. These moves mean many holders are reassessing what they are paying for. Recent news coverage has discussed...

Upcoming earnings and current sentiment Market attention is centering on PagSeguro Digital (PAGS) ahead of its upcoming quarterly results, with expectations for year-over-year growth in earnings and revenue, but recent estimate cuts are adding a layer of uncertainty for investors. See our latest analysis for PagSeguro Digital. PagSeguro Digital's share price has been choppy, with a 2.79% one day decline and a 7.92% 90 day share price return. The 1 year total shareholder return of 9.61%...

Wondering if Maximus stock is offering fair value or a potential bargain right now, especially after a tough stretch for returns. The share price last closed at US$66.66, with Maximus delivering a 1.6% return over the past week and 2.3% over the last month, but a 22.9% decline year to date and a 10.6% decline over the last year hint at changing sentiment. Recent coverage has focused on how Maximus fits into investors' long term portfolios and whether the current price reflects its...

Why Liquidity Services stock is back on investor radars Liquidity Services (LQDT) has caught investor attention after a period of solid share price momentum over the past month and past 3 months, prompting a closer look at its current valuation. See our latest analysis for Liquidity Services. While the 1 day share price return of Liquidity Services has recently dipped 2.61%, a 30 day share price return of 14.90% and 22.51% year to date, alongside a 3 year total shareholder return of 135.54%,...

In late April 2026, NeoGenomics, Inc. raised its full‑year 2026 revenue guidance to US$797.0 million–US$803.0 million and reported first‑quarter sales of US$186.67 million with a narrower net loss of US$17.11 million compared with a year earlier. The combination of stronger quarterly performance and higher revenue expectations suggests the company’s oncology testing business is gaining traction, even as it remains loss‑making. We’ll now examine how NeoGenomics’ higher 2026 revenue outlook...

RenaissanceRe Holdings (NYSE:RNR) has appointed Henry Klehm III as Non-Executive Chair, succeeding the company’s long-serving board leader. The board also renewed its share repurchase program, authorizing up to $750 million of buybacks. These moves highlight changes in board oversight and capital allocation at a time when the stock trades around $300.84. RenaissanceRe Holdings comes into this leadership change with the stock at $300.84 and multi year share price gains, including 10.5% year...

If you are wondering whether DNOW stock offers value at today’s price, the key question is how that price lines up with the company’s underlying fundamentals. The stock last closed at US$13.05, with returns of 6.3% over 30 days, a 3.3% decline over 7 days, a 2.3% decline year to date, and a 10.2% decline over 1 year. The 3 year and 5 year returns sit at 43.1% and 19.8% respectively. These mixed returns highlight that sentiment around DNOW can shift over different time frames. This often...

Wondering if KKR at around US$100 per share is starting to look like value or if the stock still prices in a lot of optimism? This article walks through that question with a clear focus on what you are paying versus what you are getting. KKR has recently seen a 10.6% return over the last 30 days, even as year to date returns sit at 22.2% in the red and the 1 year return is a 15.0% loss, on top of a very large 111.1% gain over 3 years and 90.0% over 5 years. These mixed returns come against a...

If you are wondering whether Dynex Capital's current share price offers good value or carries more risk than reward, the starting point is to look closely at how it stacks up on valuation. The stock recently closed at US$13.32, with a 7 day return of 2.2% decline, a 30 day return of 5.0%, a year to date return of 5.4% decline, and a 1 year return of 25.5%, which gives you a mix of short term setbacks and longer term gains to weigh up. Recent coverage around Dynex Capital has focused on how...

In early May 2026, Zoetis Inc. reported first-quarter sales of US$2,262 million, essentially flat net income year on year, and lowered its full-year 2026 revenue and earnings guidance after weaker-than-expected performance in its U.S. companion animal business. Management pointed to increased price sensitivity among pet owners, fewer veterinary visits, and rising competition, especially in key companion animal categories, as the main factors weighing on results and prompting the revised...

In early May 2026, Voyager Technologies, Inc. reported first-quarter sales of US$35.25 million, a net loss of US$43.98 million, and raised its full-year 2026 revenue guidance to a range of US$230 million to US$255 million, supported by a record US$275 million backlog and new defense contracts. The company is also funding new technology development while actively seeking accretive acquisitions, aiming to enhance scale, margins and its overall position across missile defense and commercial...

In early May 2026, Alarm.com Holdings reported first-quarter revenue of US$265.19 million, up from US$238.82 million a year earlier, while GAAP net income eased to US$23.58 million and diluted earnings per share from continuing operations moved to US$0.47 from US$0.52. Alongside raising its full-year 2026 outlook, the company highlighted double-digit SaaS and license revenue growth, new AI-driven video analytics features, and a US$150 million share repurchase authorization, underscoring...

Dolby Laboratories, Inc. recently reported its second-quarter fiscal 2026 results, with revenue of US$395.63 million and net income of US$94.92 million, and issued third-quarter and full-year 2026 guidance alongside confirming a quarterly dividend of US$0.36 per share and progress on its long-running share repurchase program. An interesting detail is that since the buyback’s initiation in 2009, Dolby has retired over 54.33 million shares for about US$3.16 billion, materially shrinking its...

If you are wondering whether Boeing's current share price gives you good value, it helps to separate headline noise from what the numbers actually suggest about the stock. Boeing's stock most recently closed at US$231.03, with total returns of 0.9% over 7 days, 10.0% over 30 days, 1.4% year to date, 20.5% over 1 year, 14.5% over 3 years and 3.8% over 5 years. Recent attention on Boeing has focused on safety and quality issues across parts of its commercial aircraft business, with regulatory...

Nanjing Leads Biolabs Co. Ltd. recently announced that partner Dianthus Therapeutics selected Sjögren's disease, systemic lupus erythematosus, and dermatomyositis as priority indications for LBL-047, while Dianthus also reported a wider first-quarter 2026 net loss of US$40.83 million alongside an upsized public offering that raised about US$719 million. The decision to advance LBL-047, a bifunctional fusion protein targeting both pDC-driven Type 1 interferon and BAFF/APRIL B‑cell pathways,...

Why Grab’s Q1 earnings matter for shareholders Grab Holdings (GRAB) reported first quarter 2026 revenue of US$955 million and net income of US$136 million, both higher than a year earlier, with earnings surpassing analyst expectations and indicating improved operational efficiency. See our latest analysis for Grab Holdings. The Q1 beat and updates on AI products, autonomous rides and financial services come against a mixed share price backdrop, with a 6.5% 1 month share price return but a...

Rocket Companies, Inc. reported past first-quarter 2026 results with revenue rising to US$2.94 billion from US$1.10 billion a year earlier, swinging from a US$10 million net loss to US$297 million in net income and returning to positive earnings per share. Management linked this performance to over US$500 million of AI investment, faster-than-planned integration of Mr. Cooper and Redfin, and a shift toward recurring or less rate-sensitive revenue streams that now account for roughly 70% of...

Newell Brands (NWL) is drawing fresh attention after unveiling a Toy Story 5 themed Sharpie and Elmer’s collection with Disney and Pixar, a marketing driven collaboration that could influence how investors view the stock. See our latest analysis for Newell Brands. The Toy Story 5 collaboration lands after a volatile stretch, with a 30 day share price return of 25% and a year to date share price gain of 19.62%. This is set against a 1 year total shareholder return decline of 10.18%, which...

Synaptics recently reported third-quarter fiscal 2026 results, with revenue rising to US$294.2 million from US$266.6 million a year earlier, while its net loss narrowed to US$8.0 million from US$21.8 million. Beneath the headline numbers, management emphasized rapidly growing Core IoT sales, expanding Physical AI and Edge AI design wins, and a deepening collaboration with Google on next-generation AI hardware platforms. Next, we’ll explore how the strong Core IoT growth and Physical AI...

Key recent performance and business mix Stewart Information Services (STC) has seen mixed share price moves recently, with a gain over the past month alongside a small decline over the past 3 months and year to date. The stock’s past year total return of 11.5% contrasts with a modest loss over the past 3 years. Over 5 years, the total return stands at 35.96%, giving investors a varied performance profile to assess. On the fundamentals side, the company reports annual revenue of US$3.10b and...

In the past quarter, Roper Technologies reported Q1 2026 adjusted DEPS of US$5.16, 11.3% revenue growth, raised its full-year profit outlook, and arranged a US$3.50 billion revolving credit facility to support future acquisitions. A key takeaway is that AI-driven demand across Roper’s software portfolio is becoming a central earnings driver while the larger credit line enhances financial flexibility for further portfolio expansion. We’ll now examine how Roper’s raised profit outlook,...

ACADIA Pharmaceuticals (ACAD) is back in focus after first quarter 2026 results showed 10% year over year revenue growth to US$268.1 million, alongside weaker earnings, higher expenses, and a setback for trofinetide in Europe. See our latest analysis for ACADIA Pharmaceuticals. The mixed Q1 2026 update, together with the negative EU opinion on trofinetide and leadership changes in research and development, appears to be feeding into a share price that has struggled year to date despite a...

Xeris Biopharma Holdings (XERS) stock is in focus after the company reported a profitable first quarter of 2026 and raised its full year revenue guidance to US$380 million to US$390 million. See our latest analysis for Xeris Biopharma Holdings. The guidance hike and first quarter profit have come after a mixed period for the stock, with a 12.95% 1 month share price return and a 9.80% year to date share price decline. At the same time, 1 year and 3 year total shareholder returns of 28.49% and...

IES Holdings (IESC) shares have been moving after the company reported second quarter 2026 earnings, with higher sales, net income, and earnings per share compared with the same period a year earlier. See our latest analysis for IES Holdings. The earnings release and the recent agreement to acquire Broadwind's Abilene facility have come alongside strong share price momentum, with a 30 day share price return of 38.13% and a 1 year total shareholder return of 165.60%. Multi year total...